Standards of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry.

Pesce, A J; Rashkin, M; Kotagal, U

Pesce, A J; Rashkin, M; Kotagal, U.

Affiliation

Pesce AJ; Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Ohio 45267, USA. amadeo.pesce@UC.edu

Clin Chem ; 44(5): 1124-8, 1998 May.

Article in En | MEDLINE | ID: mdl-9590396

Subject(s)

Bronchodilator Agents/blood; Caffeine/blood; Drug Monitoring/standards; Theophylline/blood; Apnea/blood; Apnea/drug therapy; Bronchodilator Agents/administration & dosage; Bronchodilator Agents/adverse effects; Bronchodilator Agents/therapeutic use; Caffeine/administration & dosage; Caffeine/adverse effects; Caffeine/therapeutic use; Humans; Infant, Newborn; Lung Diseases, Obstructive/blood; Lung Diseases, Obstructive/drug therapy; Quality Control; Specimen Handling/standards; Theophylline/administration & dosage; Theophylline/adverse effects; Theophylline/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Theophylline / Bronchodilator Agents / Caffeine / Drug Monitoring Type of study: Guideline Limits: Humans / Newborn Language: En Journal: Clin Chem Journal subject: QUIMICA CLINICA Year: 1998 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links